CN116783209A - 用于cns或肌肉递送的重组腺相关病毒 - Google Patents

用于cns或肌肉递送的重组腺相关病毒 Download PDF

Info

Publication number
CN116783209A
CN116783209A CN202180066787.XA CN202180066787A CN116783209A CN 116783209 A CN116783209 A CN 116783209A CN 202180066787 A CN202180066787 A CN 202180066787A CN 116783209 A CN116783209 A CN 116783209A
Authority
CN
China
Prior art keywords
gly
aav
capsid
pro
asn
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202180066787.XA
Other languages
English (en)
Chinese (zh)
Inventor
O·达诺斯
S·尤思特
A·默瑟
Y·刘
J·布鲁德尔
S·卡鲁木瑟尔-美乐瑟尔
E·菲恩贝格
R·钱
A·R·特佩
J·M·艾格雷
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bio Regeneration Co ltd
Original Assignee
Bio Regeneration Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bio Regeneration Co ltd filed Critical Bio Regeneration Co ltd
Priority claimed from PCT/US2021/054058 external-priority patent/WO2022076750A2/en
Publication of CN116783209A publication Critical patent/CN116783209A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/005—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered
    • A61K48/0058—Nucleic acids adapted for tissue specific expression, e.g. having tissue specific promoters as part of a contruct
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Neurosurgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
CN202180066787.XA 2020-10-07 2021-10-07 用于cns或肌肉递送的重组腺相关病毒 Pending CN116783209A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063088988P 2020-10-07 2020-10-07
US63/088,988 2020-10-07
PCT/US2021/054058 WO2022076750A2 (en) 2020-10-07 2021-10-07 Recombinant adeno-associated viruses for cns or muscle delivery

Publications (1)

Publication Number Publication Date
CN116783209A true CN116783209A (zh) 2023-09-19

Family

ID=86184347

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202180066787.XA Pending CN116783209A (zh) 2020-10-07 2021-10-07 用于cns或肌肉递送的重组腺相关病毒

Country Status (9)

Country Link
US (1) US20230374541A1 (cg-RX-API-DMAC7.html)
EP (1) EP4225778A2 (cg-RX-API-DMAC7.html)
JP (1) JP2023545384A (cg-RX-API-DMAC7.html)
KR (1) KR20230082613A (cg-RX-API-DMAC7.html)
CN (1) CN116783209A (cg-RX-API-DMAC7.html)
AU (1) AU2021358546A1 (cg-RX-API-DMAC7.html)
CA (1) CA3193685A1 (cg-RX-API-DMAC7.html)
IL (1) IL301563A (cg-RX-API-DMAC7.html)
MX (1) MX2023003807A (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024044725A2 (en) * 2022-08-24 2024-02-29 Regenxbio Inc. Recombinant adeno-associated viruses and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20230048025A1 (en) * 2016-12-22 2023-02-16 Oregon Health & Science University Adeno associated viral vectors
EP3583220A4 (en) * 2017-02-15 2021-07-07 The University of North Carolina at Chapel Hill PROCEDURES AND COMPOSITIONS FOR GENERAL TRANSFER IN THE VASCULAR SYSTEM
CN119390787A (zh) * 2019-01-31 2025-02-07 俄勒冈健康与科学大学 用于aav衣壳的使用转录依赖性定向进化的方法

Also Published As

Publication number Publication date
AU2021358546A1 (en) 2023-06-08
KR20230082613A (ko) 2023-06-08
EP4225778A2 (en) 2023-08-16
AU2021358546A9 (en) 2024-02-08
US20230374541A1 (en) 2023-11-23
MX2023003807A (es) 2023-04-12
CA3193685A1 (en) 2022-04-14
JP2023545384A (ja) 2023-10-30
IL301563A (en) 2023-05-01

Similar Documents

Publication Publication Date Title
JP7619958B2 (ja) 組換えアデノ随伴ウイルス及びその使用
WO2022076750A2 (en) Recombinant adeno-associated viruses for cns or muscle delivery
US20250001006A1 (en) Recombinant adeno-associated viruses for targeted delivery
AU2022203494B2 (en) Adeno-Associated Virus Variant Capsids And Use For Inhibiting Angiogenesis
US20230381341A1 (en) Adeno-associated viruses for ocular delivery of gene therapy
US12146151B2 (en) Cross-species compatible adeno-associated virus compositions and methods of use thereof
JP2022544004A (ja) 操作された核酸調節エレメントならびにその使用方法
US20260055144A1 (en) Recombinant adeno-associated viruses and uses thereof
WO2023201277A1 (en) Recombinant adeno-associated viruses for cns tropic delivery
US20260115322A1 (en) Recombinant tert-encoding viral genomes and vectors
JP2023545384A (ja) 中枢神経系または筋肉送達のための組換えアデノ随伴ウイルス
EP4413019A2 (en) Recombinant adeno-associated viruses for cns tropic delivery
WO2024216244A9 (en) Targeting aav capsids, methods of manufacturing and using same
CN116568815A (zh) 用于基因疗法的眼部递送的腺相关病毒
WO2025217214A2 (en) Recombinant adeno-associated viruses and uses thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination